(Q48119335)

8 February 2018

title

Dopamine receptors, antipsychotic action and schizophrenia. (English)

1 reference

8 February 2018

1 reference

G P Reynolds

1

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

8 February 2018

Journal of Psychopharmacology

published in

1 reference

8 February 2018

volume

13

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

202-203

1 reference

8 February 2018

Monoaminergic synapses and schizophrenia: 45 years of neuroleptics

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

The importance of dopamine D4 receptors in the action and development of antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

Dopamine D4 receptors elevated in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119901300220

10.1177/026988119901300220

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10475731

1 reference

8 February 2018